Acumen Pharmaceuticals Inc (ABOS)

2.37 ↓0.02 (-0.84%)
As of December 31, 1969, 7:00pm EST.

ABOS Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $2.14 - $4.64
  • Market Capitalization: $143.59M
  • Short Percentage: 3.23%
  • Target Price: $10.80
  • Shares Outstanding: 60.08M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-03-30
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $4.31 Close: -7.89% Next Day: -9.28% Next Week: -6.26% View More
0 Comments Share
2022-05-16
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $3.36 Close: -3.87% Next Day: +8.63% Next Week: +2.68% View More
0 Comments Share
2022-08-15
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $5.41 Close: 0.00% Next Day: +4.44% Next Week: -7.39% View More
0 Comments Share
2022-11-14
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $6.00 Close: +2.33% Next Day: +7.50% Next Week: +5.83% View More
0 Comments Share
2023-03-27
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $4.21 Close: 0.00% Next Day: -4.75% Next Week: +2.38% View More
0 Comments Share
2023-05-15
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $5.54 Close: +11.91% Next Day: +1.26% Next Week: -4.15% View More
0 Comments Share
2023-08-14
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $7.12 Close: +1.40% Next Day: 0.00% Next Week: -7.44% View More
0 Comments Share
2023-11-13
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $2.07 Close: -1.93% Next Day: +2.90% Next Week: +14.01% View More
0 Comments Share
2024-03-25
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $4.30 Close: -1.16% Next Day: -12.79% Next Week: -6.74% View More
0 Comments Share
2024-05-06
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $3.53 Close: +0.85% Next Day: -4.82% Next Week: -4.82% View More
0 Comments Share
2024-08-06
Earnings

ABOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $2.86 Close: +0.35% Next Day: -6.99% Next Week: -3.15% View More
0 Comments Share
Help your fellow traders

Company Info

Stock Details

  • Current Price: $2.37
  • 52-Week Low: $2.14
  • 52-Week High: $4.64
  • Most Recent Quarter: 2024-09-30
  • Shares Float: 32.42M
  • Shares Outstanding: 60.08M
  • Market Capitalization: $143.59M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 3.23%

The short interest for Acumen Pharmaceuticals Inc is at 3.23%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 10.27%
Insiders: 11.24%
Instutitions: 78.49%

Analyst Target Price

10.80

Acumen Pharmaceuticals Inc is currently $8.41 below Wallstreet Analysts' price target.

Yesterday's Volume

180,507

Interest in Acumen Pharmaceuticals Inc has been trending down. The average daily volume in the past 14 days is 214,136.

Discussions

Please log in or register to share your thoughts.

aussie71311/16/24 11:32am

$ABOS looking ready to breakout soon.

0 Like Report
HousewifeTrader2/19/24 05:03pm

$ABOS one of the poorest performed stocks for a big name.

0 Like Report